Yingqing Wang Selected Research

Neuroblastoma

10/2019

Beneficial effects of PGC-1α in the substantia nigra of a mouse model of MPTP-induced dopaminergic neurotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingqing Wang Research Topics

Disease

6	Parkinson Disease (Parkinson's Disease) 01/2024 - 07/2018
3	Neoplasms (Cancer) 04/2018 - 09/2017
1	Dyskinesias (Dyskinesia) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2019
1	Neuroblastoma 10/2019
1	Parkinsonian Disorders (Parkinsonism) 07/2018
1	Body Weight (Weight, Body) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 09/2017
1	Breast Neoplasms (Breast Cancer) 09/2017

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 04/2023 - 07/2018
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2024
1	Fish OilsIBA 01/2023
1	Apomorphine FDA Link 01/2021
1	Pramipexole (Mirapex)FDA LinkGeneric 01/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021
1	rotigotine FDA Link 01/2021
1	ropinirole (Requip)FDA LinkGeneric 01/2021
1	amsonic acid (DAS)IBA 01/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2019
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 10/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2019
1	Estrogens (Estrogen)FDA Link 10/2019
1	Nuclear Respiratory Factor 1IBA 10/2019
1	GA-Binding Protein Transcription FactorIBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 07/2018
1	SynucleinsIBA 07/2018
1	alpha-SynucleinIBA 07/2018
1	molibresibIBA 04/2018
1	LactamsIBA 01/2018
1	tanshinoneIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	Caspase 3 (Caspase-3)IBA 01/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2017

Therapy/Procedure

3	Therapeutics 07/2018 - 09/2017